Frier Levitt’s Life Sciences and Pharmacy Transactions Group maintains a national practice focused on mergers and acquisitions, joint ventures, partnerships and affiliations involving pharmacies and pharmacy-related businesses. With deep regulatory acumen and a proven track record in pharmacy M&A, we structure and negotiate transactions that achieve our clients’ strategic goals while mitigating regulatory, payor, and operational risks.
Our attorneys advise clients on both the buy-side and sell-side of pharmacy and life sciences transactions, with particular emphasis on middle-market and lower-middle-market transactions involving independent retail pharmacies, specialty pharmacies, 503A and 503B compounding pharmacies, long-term care pharmacies, and home infusion pharmacies.
With a deep understanding of the life sciences regulatory environment, Frier Levitt structures transactions that align with each client’s strategic, financial, and operational objectives. Our team develops innovative strategies and transaction models designed to help clients achieve both short-term goals and long-term sustainability. We guide clients through mergers, acquisitions, and collaborative ventures that provide opportunities for realization of value, financial stability, economies of scale, enhanced management expertise, and access to new technologies.
Beyond providing end-to-end guidance and support for the transaction itself, Frier Levitt guides clients through post-closing compliance with regulatory and third-party payor requirements as well as contractual relationships that are aligned with the parties’ shared long-term vision for the business, supporting lasting success and compliance.
Who We Represent
Our Healthcare Transactions Group represents a diverse group of healthcare providers and businesses, including:
- Physicians and other healthcare providers
- Single-specialty and multi-specialty integrated group medical practices
- Dentists and dental practices
- Hospitals and health systems
- Ambulatory surgery centers (ASCs)
- Urgent care centers
- Management service organizations (MSOs)
- Dental service organizations (DSOs)
- Entrepreneurs and other industry investors
Transactional Matters
Our attorneys routinely advise clients on a broad spectrum of transactional matters, including:
- Mergers and acquisitions (M&A)
- Private equity transactions
- Sales and acquisitions of assets, stock and other equity interests
- Bolt-on and tuck-in transactions
- Joint ventures and strategic affiliations
- Professional services arrangements
- Executive and provider employment agreements
- Commercial lease arrangements
Our Services
Frier Levitt counsels clients throughout the entire lifecycle of a transaction, from early planning through post-closing integration, providing guidance on:
- Go-to-market strategies
- Deal structuring
- Buy-side and sell-side due diligence review
- Compliance with the Anti-Kickback Statute, Stark Law and corporate practice of medicine doctrines
- Navigating licensing and permit issues
- Preparation and negotiation of front-end documents, including letters of intent, non-disclosure agreements and exclusivity agreements
- Drafting and negotiation of definitive transaction documents, including:
- Asset and equity purchase agreements
- Contribution, subscription, and redemption agreements
- Employment, professional services, and management services agreements
- Recruitment agreements
- Space and equipment leases
Representative Matters
Our attorneys have served as transactional and regulatory counsel in numerous complex, high-value healthcare transactions, including:
- Served as transactional and regulatory counsel for a 200+ provider, Connecticut-based OB/GYN practice in an asset sale to a private equity-backed management services organization for $63,400,000 cash plus rollover equity in a parent company, as well as the subsequent sale event of the parent company.
- Served as transactional and regulatory counsel on behalf of an ambulatory surgery center in connection with the sale of 51% of its equity to a leading ASC management services platform for $10,665,000.
- Served as transactional and regulatory counsel on behalf of 150+ provider, New Jersey-based platform OB/GYN practice in connection with a sale to a private equity-backed management services organization for over $46,000,000 cash plus rollover equity in a parent company.
- Served as transactional and regulatory counsel on behalf of a New Jersey-based platform gastroenterology practice in connection with a reorganization and sale of 51% of its equity to a major health system for over $40,000,000.
- Served as transactional and regulatory counsel on behalf of a vascular surgery practice and its physician-owned management services organization in connection with the sale of 51% equity in the MSO to a private equity-backed practice management platform for $35,000,000 in cash and rollover equity in a parent company.
- Served as transactional and regulatory counsel on behalf of an ambulatory surgery center in connection with the sale of 51% of its equity to a leading ASC management services platform for $11,000,000.
- Served as transactional and regulatory counsel on behalf a physician-hospital joint venture in connection with the acquisition and integration of several “bolt-on” medical practices into the joint venture’s platform.
- Served as transactional and regulatory counsel on behalf of a physician-owned holding company in connection with the sale of 100% of its equity in a regional management services organization to a leading, private equity-backed practice management platform in women’s healthcare in exchange for $35,000,000 in cash and rollover equity.
- Served as transactional and regulatory counsel on behalf of a physician-owned management services organization in connection with the sale of 100% of the equity in the MSO (together with its affiliated clinically integrated network) to a newly formed, private equity-backed practice management platform in exchange for $21,000,000.
- Served as transactional and regulatory counsel on behalf of a Nevada-based platform OB/GYN practice and its physician-owned management services organization in connection with the sale of 50% equity in the MSO to a leading, private equity-backed practice management platform in women’s healthcare for $28,665,000.
- Served as lead transactional and regulatory counsel on behalf of a leading Washington-based oncology practice in connection with a strategic joint venture with a regional health system pursuant which a health system subsidiary acquired a 49% of the equity in the practice in exchange for $16,405,839.
- Served as transactional and regulatory counsel on behalf of 50+ provider multispecialty medical practice in connection with a long-term professional services arrangement with a regional health system.
- Served as transactional and regulatory counsel on behalf of a New Jersey-based platform pediatric practice in connection with a reorganization and sale of 51% equity to a major health system for over $13,000,000.
- Served as transactional and regulatory counsel on behalf of a Pennsylvania-based platform OB/GYN practice in connection with a sale to a private equity-backed management services organization in exchange for over $20,000,000 in cash and rollover equity in a parent company.
- Served as transactional and regulatory counsel on behalf of a New Jersey-based dermatology practice in connection with an asset sale to a leading private equity-backed management services organization in exchange for $16,000,000.
- Served as transactional and regulatory counsel on behalf of a Texas-based OB/GYN practice in connection with the merger of the practice with physician platform for $10,960,000 cash and rollover equity in a regional MSO.
Why Frier Levitt
Frier Levitt combines transactional sophistication with regulatory depth – a critical advantage in the healthcare industry. Our attorneys are both skilled negotiators and regulatory advisors, ensuring that every transaction structure not only achieves your business goals but also withstands regulatory scrutiny.
Whether you are a private equity fund, investor, or organization seeking to expand, Frier Levitt offers the experience and insight to maximize value, mitigate risk, and drive success in today’s evolving healthcare and life sciences marketplace.
How Frier Levitt Can Help
Frier Levitt provides strategic, industry-focused legal counsel tailored to your needs. Contact our team today to learn how we can help you.
